Day: May 22, 2024

Laxxon Medical Announces Development Program for Non-Invasive, 3D Printed Oral GLP-1 Asset, Offering an Alternative to GLP-1 Injections on Market

Using their SPID®-Technology, Laxxon Medical has manufactured a 3D printed oral tablet combining a GLP-1 receptor agonist and a permeation...

Is this 911 call truly an emergency? ESO Research looks at dispatch protocols and patient outcomes to understand 911 prioritization measures

Study represents a significant step in enhancing emergency response amid rising call volume and resource constraints.AUSTIN, Texas--(BUSINESS WIRE)--ESO, a leading...

Rapid Dose Therapeutics and McMaster University’s Incorporation of Loratadine-Cyclodextrin Complexes in Oral Thin Films for Rapid Drug Delivery

Burlington, Ontario--(Newsfile Corp. - May 22, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") trading on...

error: Content is protected !!